Jarrod Panza

Jarrod Panza is a seasoned executive in the life sciences industry, Jarrod has helped growth-stage companies deliver scalable and sustained commercial success and select and execute strategic partnerships, including $25B in transactions, in his 20-year career.

Jarrod has served as Head of Corporate Development & Legal at Roswell Biotechnologies, an ‘omics on chip’ biotech based in San Diego; Executive Vice President - Corporate Development and General Counsel at Accumen, Inc., a leading healthcare operations company (through its acquisition by Arsenal Capital Partners in 2019); Head of Corporate Legal at the medical device company, NuVasive; and Senior Corporate Counsel of Governance, Securities, and M&A at LIFE Technologies (through its acquisition by Thermo Fisher Scientific). Jarrod has also served as a Strategic Business advisor to the Hydrafacial Company (through its IPO in 2021) and for Mesa Biotech, helping lead its integration into Thermo Fisher Scientific.